Who owns Monopar Therapeutics?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of MNPR from SEC Form 13F filings across 95 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 95 institutions disclosed 6.2M shares of Monopar Therapeutics worth $576.1M — about 72.8% of shares outstanding; the largest disclosed holder is Jupiter Topco LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
95
13F holders
$576.1M
value, 2026 filers
72.8%
of shares outstanding (6.2M sh)
30
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of MNPR's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Jupiter Topco LLCNEW | 1.3M | $121.7M | 0.0% | 15.4% | new |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 667,207 | $61.8M | 0.5% | 7.8% | 0.0% |
| 3 | BlackRock, Inc. | 348,819 | $32.3M | 0.0% | 4.1% | +10.2% |
| 4 | DEERFIELD MANAGEMENT COMPANY, L.P. | 323,745 | $30.0M | 0.3% | 3.8% | 0.0% |
| 5 | Saturn V Capital Management LP | 311,976 | $28.9M | 4.1% | 3.7% | -9.7% |
| 6 | Siren, L.L.C. | 270,118 | $25.0M | 0.5% | 3.2% | 0.0% |
| 7 | ADAR1 Capital Management, LLC | 217,595 | $20.1M | 0.9% | 2.5% | -17.7% |
| 8 | Polar Capital Holdings Plc | 214,469 | $19.9M | 0.0% | 2.5% | -5.3% |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | 209,711 | $19.4M | 0.0% | 2.5% | -4.0% |
| 10 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 209,195 | $19.4M | 0.0% | 2.4% | -32.3% |
| 11 | TCG Crossover Management, LLC | 203,327 | $18.8M | 0.5% | 2.4% | +53.9% |
| 12 | WELLINGTON MANAGEMENT GROUP LLP | 158,437 | $14.7M | 0.0% | 1.9% | -9.1% |
| 13 | ORBIMED ADVISORS LLCNEW | 157,423 | $14.6M | 0.3% | 1.8% | new |
| 14 | Candriam S.C.A.NEW | 143,339 | $13.3M | 0.1% | 1.7% | new |
| 15 | Balyasny Asset Management L.P. | 134,543 | $12.5M | 0.0% | 1.6% | -1.4% |
| 16 | GEODE CAPITAL MANAGEMENT, LLC | 112,578 | $10.4M | 0.0% | 1.3% | +12.7% |
| 17 | Alyeska Investment Group, L.P. | 100,000 | $9.3M | 0.0% | 1.2% | 0.0% |
| 18 | STATE STREET CORP | 92,551 | $8.6M | 0.0% | 1.1% | +4.7% |
| 19 | Vivo Capital, LLC | 90,500 | $8.4M | 0.8% | 1.1% | 0.0% |
| 20 | Driehaus Capital Management LLC | 84,040 | $7.8M | 0.0% | 1% | +153.5% |
| 21 | Bank of New York Mellon Corp | 76,942 | $7.1M | 0.0% | 0.9% | -2.1% |
| 22 | Vestal Point Capital, LP | 75,727 | $7.0M | 0.2% | 0.9% | +15.8% |
| 23 | Longaeva Partners L.P.NEW | 55,834 | $5.2M | 0.1% | 0.7% | new |
| 24 | NEUBERGER BERMAN GROUP LLC | 55,194 | $5.1M | 0.0% | 0.6% | +30.1% |
| 25 | MILLENNIUM MANAGEMENT LLC | 50,311 | $4.7M | 0.0% | 0.6% | -5.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.